VAERS reports by lot

Pfizer COVID-19 lot HG4675: VAERS reports

43 VAERS reports list lot HG4675 as a Pfizer COVID-19 vaccine, received between 2023-10-14 and 2024-06-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
43
Reports
9%
Marked serious
1
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Cardiac / Cardiovascular2225%
General / Systemic (non-local)1517%
Injection-site / Local reaction1517%
Neurological1213%
Musculoskeletal89%
Respiratory56%
Gastrointestinal44%
Psychiatric / Neuropsychiatric33%
Allergic / Anaphylactic22%
Dermatological (non-injection-site)22%
Thrombotic / Hematological11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Oregon5
California4
Virginia4
Minnesota3
Massachusetts3
New York3
Puerto Rico3
Washington3
Colorado2
Nebraska1
Maine1
Kentucky1

Reports by month received

2023-1012
2023-1111
2023-125
2024-019
2024-021
2024-031
2024-051
2024-063

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.